Have a personal or library account? Click to login
Transforming growth factor (TGF) – is it a key protein in mammalian reproductive biology? Cover

References

  1. 1. Stępień-Wyrobiec O, Hrycek A, Wyrobiec G. Transforming growth factor beta (TGF-beta): Its structure, function, and role in the pathogenesis of systemic lupus erythematosus. Post Hig Med Dosw. 2008;62:688–93.
  2. 2. Adorini L. Cytokine-based immunointervention in the treatment of autoimmune diseases. Clin Exp Immunol. 2003;132(2):185–92.10.1046/j.1365-2249.2003.02144.x
  3. 3. Flanders KC, Burmester JK. Medical applications of transforming growth factor-beta. Clin Med Res. 2003;1(1):13–20.10.3121/cmr.1.1.13
  4. 4. Krzemień S, Knapczyk P. Aktualne poglądy dotyczące znaczenia transformującego czynnika wzrostu beta (TGF-β) w patogenezie niektórych stanów chorobowych. Wiad Lek. 2005;58(9-10):536–9.
  5. 5. Glister C, Kemp CF, Knight PG. Bone morphogenetic protein (BMP) ligands and receptors in bovine ovarian follicle cells: actions of BMP-4, -6 and -7 on granulosa cells and differential modulation of Smad-1 phosphorylation by follistatin. Reprod. 2004;127(2):239–54; DOI:10.1530/rep.1.00090.10.1530/rep.1.00090
  6. 6. Glister C, Richards SL, Knight PG. Bone morphogenetic proteins (BMP) -4, -6, and -7 potently suppress basal and luteinizing hormone-induced androgen production by bovine theca interna cells in primary culture: could ovarian hyperandrogenic dysfunction be caused by a defect in thecal BMP signaling? Endocrinology. 2005;146(4):1883–92; DOI:10.1210/en.2004-1303.10.1210/en.2004-1303
  7. 7. Knight PG, Glister C. Local roles of TGF-beta superfamily members in the control of ovarian follicle development. Anim Reprod Sci. 2003;78(3-4):165–83.10.1016/S0378-4320(03)00089-7
  8. 8. Massagué J, Wotton D. Transcriptional control by the TGF-beta/Smad signaling system. EMBO J. 2000;19(8):1745–54; DOI:10.1093/emboj/19.8.1745.10.1093/emboj/19.8.1745
  9. 9. Moustakas A, Pardali K, Gaal A, Heldin CH. Mechanisms of TGF-beta signaling in regulation of cell growth and differentiation. Immunol Lett. 2002;82(1-2):85–91.10.1016/S0165-2478(02)00023-8
  10. 10. Border WA, Noble NA. Transforming growth factor beta in tissue fibrosis. N Engl J Med. 1994;331(19):1286–92; DOI:10.1056/NEJM199411103311907.10.1056/NEJM1994111033119077935686
  11. 11. Buck MB, Fritz P, Dippon J, Zugmaier G, Knabbe C. Prognostic significance of transforming growth factor beta receptor II in estrogen receptor-negative breast cancer patients. Clin Cancer Res. 2004;10(2):491–8.10.1158/1078-0432.CCR-0320-0314760070
  12. 12. Pepper MS, Belin D, Montesano R, Orci L, Vassalli JD. Transforming growth factor-beta 1 modulates basic fibroblast growth factor-induced proteolytic and angiogenic properties of endothelial cells in vitro. J Cell Biol. 1990;111(2):743–55.10.1083/jcb.111.2.74321162131696269
  13. 13. Ziv E, Cauley J, Morin PA, Saiz R, Browner WS. Association between the T29--C polymorphism in the transforming growth factor beta1 gene and breast cancer among elderly white women: The Study of Osteoporotic Fractures. JAMA. 2001;285(22):2859–63.10.1001/jama.285.22.285911401606
  14. 14. Ni N, Li Q. TGFβ superfamily signaling and uterine decidualization. Reprod Biol Endocrinol. 2017;15(1):75; DOI:10.1186/s12958-017-0303-0.10.1186/s12958-017-0303-0564093429029620
  15. 15. Knight PG, Glister C. TGF-beta superfamily members and ovarian follicle development. Reproduction. 2006;132(2):191–206; DOI:10.1530/rep.1.01074.10.1530/rep.1.0107416885529
  16. 16. Tanimoto K, Suzuki A, Ohno S, Honda K, Tanaka N, Doi T, Yoneno K, Ohno-Nakahara M, Nakatani Y, Ueki M, Tanne K. Effects of TGF-beta on hyaluronan anabolism in fibroblasts derived from the syno-vial membrane of the rabbit temporomandibular joint. J Dent Res. 2004;83(1):40–4; DOI:10.1177/154405910408300108.10.1177/15440591040830010814691111
  17. 17. Asano Y, Ihn H, Yamane K, Kubo M, Tamaki K. Impaired Smad7-Smurf-mediated negative regulation of TGF-beta signaling in scleroderma fibro-blasts. J Clin Invest. 2004;113(2):253–64; DOI:10.1172/JCI16269.10.1172/JCI1626931074714722617
  18. 18. Caserta TM, Knisley AA, Tan FK, Arnett FC, Brown TL. Genotypic analysis of the TGF beta-509 allele in patients with systemic lupus erythematosus and Sjogren’s syndrome. Ann Genet. 2004;47(4):359–63; DOI:10.1016/j.anngen.2004.07.003.10.1016/j.anngen.2004.07.00315581833
  19. 19. Lu L-Y, Cheng H-H, Sung P-K, Yeh J-J, Shiue Y-L, Chen A. Single-nucleotide polymorphisms of transforming growth factor-beta1 gene in Taiwanese patients with systemic lupus erythematosus. J Microbiol Immunol Infect. 2004;37(3):145–52.
  20. 20. Feinberg MW, Jain MK. Role of transforming growth factor-beta1/Smads in regulating vascular inflammation and atherogenesis. Panminerva Med. 2005;47(3):169–86.
  21. 21. Niemczyk M, Foroncewicz B, Mucha K. Rola TGF beta. Pol Arch Med Wet. 2005;113(4):401–8.
  22. 22. Luedecking EK, DeKosky ST, Mehdi H, Ganguli M, Kamboh MI. Analysis of genetic polymorphisms in the transforming growth factor-β1 gene and the risk of Alzheimer’s disease. Hum Genet. 2000;106(5):565–9; DOI:10.1007/s004390000313.10.1007/s00439000031310914688
  23. 23. Maurya VK, Jha RK, Kumar V, Joshi A, Chadchan S, Mohan JJ, Laloraya M. Transforming growth factor-beta 1 (TGF-B1) liberation from its latent complex during embryo implantation and its regulation by estradiol in mouse. Biol Reprod. 2013;89(4):84; DOI:10.1095/biolreprod.112.106542.10.1095/biolreprod.112.10654223926286
  24. 24. Wang Z-P, Mu X-Y, Guo M, Wang Y-J, Teng Z, Mao G-P, Niu W-B, Feng L-Z, Zhao L-H, Xia G-L. Transforming growth factor-β signaling participates in the maintenance of the primordial follicle pool in the mouse ovary. J Biol Chem. 2014;289(12):8299–311; DOI:10.1074/jbc.M113.532952.10.1074/jbc.M113.532952396165724515103
  25. 25. Rosairo D, Kuyznierewicz I, Findlay J, Drummond A. Transforming growth factor-beta: its role in ovarian follicle development. Reproduction. 2008;136(6):799–809; DOI:10.1530/REP-08-0310.10.1530/REP-08-031018780765
  26. 26. Li Q, Agno JE, Edson MA, Nagaraja AK, Nagashima T, Matzuk MM. Transforming Growth Factor β Receptor Type 1 Is Essential for Female Reproductive Tract Integrity and Function. PLoS Genet. 2011;7(10):e1002320; DOI:10.1371/journal.pgen.1002320.10.1371/journal.pgen.1002320
  27. 27. Robertson D. Inhibin/activin and ovarian cancer. Endocr Relat Cancer. 2004;11(1):35–49; DOI:10.1677/erc.0.0110035.10.1677/erc.0.0110035
  28. 28. Męczekalski B, Podfigurna-Stopa A. Rola inhibin w funkcjach i dysfunkcjach rozrodczych kobiety. Pol Mer Lek. 2009.
  29. 29. Makanji Y, Zhu J, Mishra R, Holmquist C, Wong WPS, Schwartz NB, Mayo KE, Woodruff TK. Inhibin at 90: From Discovery to Clinical Application, a Historical Review. Endocr Rev. 2014;35(5):747–94; DOI:10.1210/er.2014-1003.10.1210/er.2014-1003
  30. 30. Florio P, Severi FM, Cobellis L, Danero S, Bomè A, Luisi S, Petraglia F. Serum activin A and inhibin A. New clinical markers for hydatidiform mole. Cancer. 2002;94(10):2618–22.10.1002/cncr.10524
  31. 31. Welt CK, Schneyer AL. Differential regulation of inhibin B and inhibin a by follicle-stimulating hormone and local growth factors in human granulosa cells from small antral follicles. J Clin Endocrinol Metab. 2001;86(1):330–6; DOI:10.1210/jcem.86.1.7107.10.1210/jcem.86.1.7107
  32. 32. Burger HG, Fuller PJ, Chu S, Mamers P, Drummond A, Susil B, Neva P, Robertson DM. The inhibins and ovarian cancer. Mol Cell Endocrinol. 2001;180(1-2):145–8; DOI:10.1016/S0303-7207(01)00519-6.10.1016/S0303-7207(01)00519-6
  33. 33. Myers M, Middlebrook BS, Matzuk MM, Pangas SA. Loss of inhibin alpha uncouples oocyte-granulosa cell dynamics and disrupts postnatal folliculogenesis. Dev Biol. 2009;334(2):458–67; DOI:10.1016/j.ydbio.2009.08.001.10.1016/j.ydbio.2009.08.001275371719666016
  34. 34. Belli M, Shimasaki S. Molecular Aspects and Clinical Relevance of GDF9 and BMP15 in Ovarian Function. In: Ovarian Cycle: Elsevier; 2018. p. 317–48 [Vitamins and Hormones]; DOI:10.1016/bs.vh.2017.12.003.10.1016/bs.vh.2017.12.003630967829544636
  35. 35. Jee BC, Lee JR, Suh CS, Kim SH, Moon SY. Follicular fluid growth differentiation factor-9 concentration and oocyte developmental competence. J Womens Med. 2011;4(1):1; DOI:10.5468/jwm.2011.4.1.1.10.5468/jwm.2011.4.1.1
  36. 36. Teixeira Filho FL, Baracat EC, Lee TH, Suh CS, Matsui M, Chang RJ, Shimasaki S, Erickson GF. Aberrant expression of growth differentiation factor-9 in oocytes of women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2002;87(3):1337–44; DOI:10.1210/jcem.87.3.8316.10.1210/jcem.87.3.831611889206
  37. 37. Castro FCd, Cruz MHC, Leal CLV. Role of Growth Differentiation Factor 9 and Bone Morphogenetic Protein 15 in Ovarian Function and Their Importance in Mammalian Female Fertility — A Review. Asian Australas J Anim Sci. 2016;29(8):1065–74; DOI:10.5713/ajas.15.0797.10.5713/ajas.15.0797493255926954112
  38. 38. Drummond AE. TGFbeta signalling in the development of ovarian function. Cell Tissue Res. 2005;322(1):107–15; DOI:10.1007/s00441-005-1153-1.10.1007/s00441-005-1153-115983782
  39. 39. Bierie B, Moses HL. Tumour microenvironment: TGFbeta: the molecular Jekyll and Hyde of cancer. Nat Rev Cancer. 2006;6(7):506–20; DOI:10.1038/nrc1926.10.1038/nrc192616794634
  40. 40. O sterlund C, Fried G. TGFβ receptor types I and II and the substrate proteins Smad 2 and 3 are present in human oocytes. Mol Hum Reprod. 2000;6(6):498–503; DOI:10.1093/molehr/6.6.498.10.1093/molehr/6.6.49810825365
  41. 41. Miyazono K. Positive and negative regulation of TGF-beta signaling. J Cell Sci. 2000;113 (Pt 7):1101–9.10.1242/jcs.113.7.110110704361
  42. 42. Caestecker M de. The transforming growth factor-β superfamily of receptors. Cytokine Growth Factor Rev. 2004;15(1):1–11; DOI:10.1016/j.cytogfr.2003.10.004.10.1016/j.cytogfr.2003.10.00414746809
  43. 43. Derynck R, Zhang YE. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature. 2003;425(6958):577–84; DOI:10.1038/nature02006.10.1038/nature0200614534577
  44. 44. Moustakas A. Non-Smad TGF-signals. J Cell Sci. 2005;118(16):3573–84; DOI:10.1242/jcs.02554.10.1242/jcs.0255416105881
Language: English
Page range: 125 - 130
Submitted on: Oct 3, 2018
Accepted on: Oct 27, 2018
Published on: Dec 24, 2018
Published by: Foundation for Cell Biology and Molecular Biology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2018 Marta Rybska, Sandra Knap, Katarzyna Stefańska, Maurycy Jankowski, Agata Chamier-Gliszczyńska, Małgorzata Popis, Michal Jeseta, Dorota Bukowska, Paweł Antosik, Bartosz Kempisty, Jędrzej M. Jaśkowski, published by Foundation for Cell Biology and Molecular Biology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.